Stock 688575 SHENZHEN YHLO BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
23.54 CNY -1.05% Intraday chart for Shenzhen YHLO Biotech Co., Ltd. +7.98% +2.93%
Apr. 19 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+2.93% 1.85B -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+72.64% 12.34B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-18.30% 7.96B
C+
MASIMO CORPORATION Stock Masimo Corporation
+15.38% 7.16B
C-
GETINGE AB Stock Getinge AB
+3.97% 5.72B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+6.51% 5.03B
D+
APT MEDICAL INC. Stock APT Medical Inc.
+21.99% 4.35B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.99B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-41.36% 2.21B
C
SKAN GROUP AG Stock SKAN Group AG
+0.87% 2.01B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688575 Stock
  4. Ratings Shenzhen YHLO Biotech Co., Ltd.